Hikma Pharmaceuticals USA recently announced that it will invest $1 billion by 2030 to further expand U.S. manufacturing and R&D. London-based Hikma has already invested more than $4 billion over the past 15 years in expanding its U.S. presence, which was first established in 1991. The new “America Leans on Hikma” phase, announced June 28,…